These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24063977)

  • 1. NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response.
    Ibrahim AS; Luo G; Gebremariam T; Lee H; Schmidt CS; Hennessey JP; French SW; Yeaman MR; Filler SG; Edwards JE
    Vaccine; 2013 Nov; 31(47):5549-56. PubMed ID: 24063977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.
    Schmidt CS; White CJ; Ibrahim AS; Filler SG; Fu Y; Yeaman MR; Edwards JE; Hennessey JP
    Vaccine; 2012 Dec; 30(52):7594-600. PubMed ID: 23099329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
    Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
    Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-antigen fusion protein vaccination induces protective immunity against
    Jia K; Zhang Y; Jiang M; Cui M; Wang J; Zhang J; Wang H; Zhao H; Li M; Zou Q; Zeng H
    Hum Vaccin Immunother; 2024 Dec; 20(1):2406065. PubMed ID: 39327639
    [No Abstract]   [Full Text] [Related]  

  • 5. A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine.
    Sandini S; La Valle R; Deaglio S; Malavasi F; Cassone A; De Bernardis F
    FEMS Immunol Med Microbiol; 2011 Jul; 62(2):215-24. PubMed ID: 21535228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice.
    Spellberg BJ; Ibrahim AS; Avenissian V; Filler SG; Myers CL; Fu Y; Edwards JE
    Infect Immun; 2005 Sep; 73(9):6191-3. PubMed ID: 16113347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with Secreted Aspartyl Proteinase 2 Protein from
    Shukla M; Rohatgi S
    Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32661125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection.
    Singh S; Uppuluri P; Mamouei Z; Alqarihi A; Elhassan H; French S; Lockhart SR; Chiller T; Edwards JE; Ibrahim AS
    PLoS Pathog; 2019 Aug; 15(8):e1007460. PubMed ID: 31381597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid phage displaying SLAQVKYTSASSI induces protection against Candida albicans challenge in BALB/c mice.
    Wang Y; Su Q; Dong S; Shi H; Gao X; Wang L
    Hum Vaccin Immunother; 2014; 10(4):1057-63. PubMed ID: 24448202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial.
    Edwards JE; Schwartz MM; Schmidt CS; Sobel JD; Nyirjesy P; Schodel F; Marchus E; Lizakowski M; DeMontigny EA; Hoeg J; Holmberg T; Cooke MT; Hoover K; Edwards L; Jacobs M; Sussman S; Augenbraun M; Drusano M; Yeaman MR; Ibrahim AS; Filler SG; Hennessey JP
    Clin Infect Dis; 2018 Jun; 66(12):1928-1936. PubMed ID: 29697768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis.
    Huang W-C; Eberle K; Colon JR; Lovell JF; Xin H
    mSphere; 2024 Jul; 9(7):e0018924. PubMed ID: 38904363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies targeting
    Singh S; Nabeela S; Barbarino A; Ibrahim AS; Uppuluri P
    Front Immunol; 2022; 13():925821. PubMed ID: 35935947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial protection against experimental vaginal candidiasis after mucosal vaccination with heat-killed Candida albicans and the mucosal adjuvant LT(R192G).
    Cárdenas-Freytag L; Steele C; Wormley FL; Cheng E; Clements JD; Fidel PL
    Med Mycol; 2002 Jun; 40(3):291-9. PubMed ID: 12146759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice.
    Lin L; Ibrahim AS; Xu X; Farber JM; Avanesian V; Baquir B; Fu Y; French SW; Edwards JE; Spellberg B
    PLoS Pathog; 2009 Dec; 5(12):e1000703. PubMed ID: 20041174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis.
    Spellberg BJ; Ibrahim AS; Avanesian V; Fu Y; Myers C; Phan QT; Filler SG; Yeaman MR; Edwards JE
    J Infect Dis; 2006 Jul; 194(2):256-60. PubMed ID: 16779733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida vaginitis: virulence, host response and vaccine prospects.
    De Bernardis F; Graziani S; Tirelli F; Antonopoulou S
    Med Mycol; 2018 Apr; 56(suppl_1):26-31. PubMed ID: 29538739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
    Li Wq; Hu Xc; Zhang X; Ge Y; Zhao S; Hu Y; Ashman RB
    Vaccine; 2011 Jul; 29(33):5526-33. PubMed ID: 21645574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NDV-3A vaccination prevents C. albicans colonization of jugular vein catheters in mice.
    Alqarihi A; Singh S; Edwards JE; Ibrahim AS; Uppuluri P
    Sci Rep; 2019 Apr; 9(1):6194. PubMed ID: 30996274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis.
    Saville SP; Lazzell AL; Chaturvedi AK; Monteagudo C; Lopez-Ribot JL
    Clin Vaccine Immunol; 2009 Mar; 16(3):430-2. PubMed ID: 19144791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of protective effect of protein and DNA vaccines hsp90 in murine model of systemic candidiasis.
    Raska M; Beláková J; Wudattu NK; Kafková L; Růzicková K; Sebestová M; Kolár Z; Weigl E
    Folia Microbiol (Praha); 2005; 50(1):77-82. PubMed ID: 15954537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.